Advanced Drug Delivery CDMO Market
完整報告名稱與涵蓋範圍
Advanced Drug Delivery CDMO Market Size, Share & Trends Analysis Report By Service Type (Formulation Development, Process Development and Scale-Up, Analytical and Testing Services, Manufacturing Services, Packaging and, Device Development, Regulatory Support), By Technology (Targeted Drug Delivery Systems, Controlled/Sustained-Release Technologies, Injectable Delivery Platforms, Pulmonary & Nasal Delivery Systems, Transdermal & Microneedle Delivery, Mucosal Delivery Methods, Implantable Delivery Devices, 3D-Printed Drug Delivery), By Dosage Form, By Application, By End-User By Region, And By Segment Forecasts, 2025-2034
報告摘要
The Advanced Drug Delivery CDMO Market is positioned for steady expansion, with a projected CAGR of 5.0% from 2025 to 2034.
Advanced Drug Delivery CDMO covers The pharmaceutical sector greatly benefits from a Contract Development and Manufacturing Organisation (CDMO) specialising in cutting-edge drug delivery technologies. Rapid advancements and evolving end-user preferences are reshaping how materials and technology entities approach this space.
Several factors contribute to this trajectory, including heightened need next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold marked shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and growing investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Advanced Drug Delivery CDMO Market Snapshot
Chapter 4. Global Advanced Drug Delivery CDMO Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Advanced Drug Delivery CDMO Market Industry Trends
4.10. Global Advanced Drug Delivery CDMO Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Advanced Drug Delivery CDMO Market Segmentation 1: By Service Type, Estimates & Trend Analysis
5.1. Market Share by Service Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Service Type:
5.2.1. Formulation Development
5.2.2. Process Development and Scale-Up
5.2.3. Analytical and Testing Services
5.2.4. Manufacturing Services
5.2.5. Packaging and Device Development
5.2.6. Regulatory Support
Chapter 6. Advanced Drug Delivery CDMO Market Segmentation 2: By Technology, Estimates & Trend Analysis
6.1. Market Share by Technology, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology:
6.2.1. Targeted Drug Delivery Systems
6.2.1.1. Nanoparticle-Based Systems
6.2.1.1.1. Lipid Nanoparticles (LNPs)
6.2.1.1.2. Polymeric Nanoparticles
6.2.1.1.3. Inorganic Nanoparticles
6.2.1.2. Biologics-Focused Targeting
6.2.1.2.1. Antibody-Drug Conjugates (ADCs)
6.2.1.2.2. Fusion Proteins & Peptide Conjugates
6.2.1.3. Stimuli-Responsive Systems
6.2.2. Controlled/Sustained-Release Technologies
6.2.3. Injectable Delivery Platforms
6.2.4. Pulmonary & Nasal Delivery Systems
6.2.5. Transdermal & Microneedle Delivery
6.2.6. Mucosal Delivery Methods
6.2.7. Implantable Delivery Devices
6.2.8. 3D-Printed Drug Delivery
Chapter 7. Advanced Drug Delivery CDMO Market Segmentation 3: By Dosage Form Industry, Estimates & Trend Analysis
7.1. Market Share by Dosage Form Industry, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Dosage Form Industry:
7.2.1. Injectables
7.2.2. Oral Solids
7.2.3. Topical & Transdermal
7.2.4. Implantables & Ocular
Chapter 8. Offline Advanced Drug Delivery CDMO Market Segmentation 4: By Application, Estimates & Trend Analysis
8.1. Market Share by Application, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
8.2.1. Oncology
8.2.2. Infectious Diseases
8.2.3. Neurological Disorders
8.2.4. Cardiovascular Diseases
8.2.5. Other (e.g., diabetes, ophthalmology, rare diseases)
Chapter 9. Advanced Drug Delivery CDMO Market Segmentation 5: By End-User, Estimates & Trend Analysis
9.1. Market Share by End-User, 2024 & 2034
9.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:
9.2.1. Clinical
9.2.2. Commercial
Chapter 10. Advanced Drug Delivery CDMO Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Advanced Drug Delivery CDMO Market, Regional Snapshot 2024 & 2034
10.2. North America
10.2.1. North America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
10.2.3. North America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.2.4. North America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form Industry, 2021-2034
10.2.5. North America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.2.6. North America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.3. Europe
10.3.1. Europe Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
10.3.3. Europe Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.3.4. Europe Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form Industry, 2021-2034
10.3.5. Europe Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.3.6. Europe Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.4. Asia Pacific
10.4.1. Asia Pacific Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
10.4.3. Asia Pacific Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.4.4. Asia Pacific Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts Application, 2021-2034
10.4.5. Asia Pacific Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.5. Latin America
10.5.1. Latin America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
10.5.3. Latin America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.5.4. Latin America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form Industry, 2021-2034
10.5.5. Latin America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.5.6. Latin America Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.6. Middle East & Africa
10.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
10.6.3. Middle East & Africa Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.6.4. Middle East & Africa Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form Industry, 2021-2034
10.6.5. Middle East & Africa Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.6.6. Middle East & Africa Advanced Drug Delivery CDMO Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Catalent, Inc.
11.2.1.1. Business Overview
11.2.1.2. Key Service Type/Service Overview
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Lonza Group AG
11.2.3. Kindeva Drug Delivery
11.2.4. MedPharm (merged with Tergus Pharma)
11.2.5. WuXi AppTec
11.2.6. Hovione
11.2.7. Piramal Pharma Solutions
11.2.8. CordenPharma International
11.2.9. Divi's Laboratories
11.2.10. Lifecore Biomedical
11.2.11. Recipharm AB
11.2.12. Syngene International
11.2.13. Thermo Fisher Scientific (Patheon)
11.2.14. Aenova Group
11.2.15. Cellipoint Bioservices
11.2.16. Evonik Health Care
11.2.17. SHL Medical
11.2.18. Lubrizol Life Science
11.2.19. Acino International AG
11.2.20. Pharmathen
11.2.21. Phillips-Medisize (A Molex Company)
11.2.22. Others
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們